AI Summary

A clinical trial coordinated by Rockefeller, Imperial College London and the University of Oxford demonstrated that administering one or two doses of broadly neutralizing antibodies can maintain HIV at undetectable levels for months or years. The approach offers a potential alternative to lifelong daily antiretroviral therapy, which currently has no cure. Researchers observed long‑term viral suppression after the limited antibody treatment, indicating a new strategy for controlling the infection.

AI summaries can be wrong sometimes—always verify important details using the source article.